Broadcom's Biggest Customers Want To Slow AI Down

Broadcom maintains a Strong Buy rating, supported by $350 billion of AI-chip shipments secured for fiscal 2027-2028. The company targets AI revenue of $115 billion in 2027 and $230 billion in 2028, with demand underpinned by locked supply and customer power constraints. Higher capex is intended to relieve supply bottlenecks, while operating margin remains robust at 67.9% and AI accounts for 56% of total revenue.

Analysis

The investable issue is not demand visibility alone, but whether AVGO can convert backlog into incremental earnings without giving up economics to foundry, advanced-packaging, and HBM suppliers. Custom silicon expands the addressable pool beyond merchant GPUs, but it also increases customer concentration: a delayed hyperscaler cluster build or an internal accelerator redesign can shift revenue recognition materially even when aggregate AI spending remains healthy. Near term, the market is likely to reward supply-capacity milestones and customer program disclosures more than further headline demand targets.

AVGO's scale-up creates second-order beneficiaries in TSMC (TSM), advanced packaging and networking/optics, while pressuring the relative AI narrative for GPU-centric vendors where hyperscalers substitute a portion of inference and internal workloads toward ASICs. The margin debate becomes more important over the next 12-24 months: higher mix of custom programs can sustain revenue growth but may carry lower gross-margin or working-capital characteristics than software and legacy semiconductor content. A sustained premium multiple requires evidence that operating leverage offsets this mix change.

Consensus appears vulnerable to treating stated long-duration supply commitments as equivalent to unconditional revenue. The more relevant diligence items are cancellation provisions, customer prepayment terms, wafer commitments, packaging allocation, and the concentration of the largest two or three programs. Falsification would be a reduction in AI growth guidance, a sequential gross-margin decline not explained by acquisition accounting, or hyperscaler capex guidance turning from capacity expansion to utilization optimization; these would likely matter within one to two quarters rather than at the end-market demand horizon.

Key Decisions for Investors

• Maintain/add AVGO on 3-6 month pullbacks rather than chase strength; use the next earnings report to require disclosed supply-capacity progress and no deterioration in gross-margin trajectory. Risk/reward is favorable only if AI guidance is reaffirmed while valuation remains below the implied upside from 2027 earnings; trim if management signals customer-specific deployment delays.
• Express custom-silicon share gains as a 6-12 month pair: long AVGO / short a basket proxy of merchant-AI exposure led by NVDA, sized beta-neutral. The thesis is workload substitution at hyperscalers, not an absolute bearish view on AI; exit if NVDA demonstrates accelerating non-GPU demand or AVGO discloses lower-than-expected custom-program margins.
• Add TSM to the AI supply-chain watchlist as a potential 6-18 month second-order beneficiary, contingent on evidence that advanced-packaging capacity is the binding constraint. Do not initiate solely on AVGO guidance: confirm with TSM monthly revenue, CoWoS capacity commentary, and customer prepayment disclosures.
• Buy downside protection on AVGO around earnings if implied volatility is below realized post-guidance move levels; a 1-3 month put spread is preferable to reducing core exposure. The key downside catalyst is not weak AI demand broadly, but a single-customer timing shift that challenges backlog quality and compresses the premium multiple.